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ABSTRACT 
 The cholinergic neurons which originate in the mesopontine tegmentum and innervate 
the midbrain ventral tegmental area have been proposed to play a key role in intracranial self-
stimulation reward. This mesopontine area also contains GABA neurons. Detailed 
information is still lacking, however, about the relationship of cholinergic and GABA-ergic 
neurons in this region to self-stimulation reward. Therefore, using double immunostaining for 
Fos as a marker of neuronal activity and choline acetyltransferase as a marker of cholinergic 
neurons, or for Fos and GABA, we investigated whether self-stimulation of the medial 
forebrain bundle induces Fos expression within cholinergic and GABA-ergic neurons in two 
regions of the mesopontine tegmentum, i.e., pedunculopontine tegmental nucleus and 
laterodorsal tegmental nucleus. Self-stimulation of the medial forebrain bundle for one hour 
induced a large increase in the number of cells expressing Fos in both the pedunculopontine 
tegmental nucleus and laterodorsal tegmental nucleus, when compared to control brains. 
However, the self-stimulation-induced expression of Fos was restricted mostly to GABA-, 
but not choline acetyltransferase-, immunostained cells. We also examined, using 
microdialysis, whether self-stimulation increases acetylcholine efflux in the ventral tegmental 
area, a terminal region of the mesopontine tegmentum cholinergic pathway. One-hour of self-
stimulation significantly increased acetylcholine efflux from this terminal area. The results 
indicate that intracranial self-stimulation of the medial forebrain bundle may increase 
acetylcholine release without affecting expression of Fos in cholinergic neurons, while the 
same stimulation may induce Fos expression in GABA-ergic neurons of the mesopontine 
tegmentum. GABA-ergic as well as cholinergic neurons in this area appear to be activated by 
self-stimulation reward in the medial forebrain bundle. 
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 Although mesoaccumbal dopamine is considered important in the mediation of 
intracranial self-stimulation (ICSS) behavior (Phillips and Fibiger, 1978; Fibiger and Phillips, 
1987;Wise and Rompre, 1989), its role seems to be modulatory (Garris et al., 1999; 
Miliaressis et al., 1991; Zacharko and Anisman, 1991).Several recent studies have 
demonstrated that ICSS of the medial forebrain bundle (MFB) or ventral tegmental area 
(VTA) increases the expression of Fos, an anatomical marker of cellular activation, in many 
brain regions where catecholaminergic or serotonergic cell bodies are found (Arvanitogiannis 
et al., 1996, 1997; Flores et al., 1997; Hunt and McGregor, 1998; Nakahara et al., 1999). 
Furthermore, one preliminary but noteworthy report using a double labeling technique for 
Fos and tyrosine hydroxylase (TH), an indicator of catecholamine neurons, has revealed that 
most of the TH-immunoreactive cells in the VTA of self-stimulating rats did not express Fos 
(Hunt and McGregor, 1998). Recently, our quantitative analysis using a combined 
immunostaining method for Fos and serotonin (5-HT) or for Fos and TH extended this 
finding and proved that the percentage of Fos/TH double-labeled cells in association with 
ICSS was approximately 54% of all Fos-positive cells in the locus coeruleus and only 13% in 
the VTA, whereas 38% of Fos-labeled cells contained 5-HT in the dorsal raphe (Ishida et al., 
2001). Interestingly, the same study also found that a relatively large portion (61-88%) of 
these Fos-positive cells were GABA-ergic neurons, which are co-distributed with 
monoaminergic neurons in the VTA, locus coeruleus and dorsal raphe (Ishida et al., 2001). 
Thus, it was suggested that the ICSS-induced expression of Fos protein was evidently 
different among the three cell populations, and that 5-HT, noradrenaline and GABA as well 
as dopamine may also play some role in the expression of ICSS behavior.  
 Acetylcholine (ACh) has been considered another important transmitter related to 
ICSS reward. It has been reported that the rewarding effects of ICSS are strongly inhibited or 
blocked by cholinergic antagonists infused in the VTA (Rada et al., 2000; Yeomans and 
Baptista, 1997), or by cholinergic agonists in the PPTg where muscarinic ACh receptors are 
inhibitory (Yeomans et al., 1993). Several lines of evidence have proposed that ICSS of the 
MFB directly activates non-dopaminergic, descending myelinated axons that connect 
monosynaptically and/or multisynaptically to dopaminergic cells of the VTA (Bielajew and 
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Shizgal, 1986; Gallistel et al., 1981; Yeomans 1989, 1995). One of the important 
multisynaptic pathways comes from cholinergic neurons of the mesopontine tegmentum 
(Yeomans, 1995; Yeomans et al., 1993). Thus, mesopontine cholinergic input can activate the 
ascending mesoaccumbal dopaminergic pathway, which is responsible for the initiation of 
ICSS behavior (Garris et al., 1999). Moreover, the mesopontine tegmentum contains many 
GABA-ergic neurons which are co-distributed with the cholinergic neurons (Ford et al., 
1995; Honda and Semba, 1995; Jones, 1991b). However, the effects of ICSS on the Fos 
expression in cholinergic as well as GABA-ergic cells of the mesopontine tegmentum have 
not been reported. 
 In the present study, therefore, we used double immunostaining for Fos and choline 
acetyltransferase (ChAT) as an index of cholinergic neurons, or for Fos and GABA to clarify 
the neurotransmitter phenotype of neurons expressing Fos following ICSS of the MFB in two 
regions of the mesopontine tegmentum, i.e., pedunculopontine tegmental nucleus (PPTg) and 
laterodorsal tegmental nucleus (LDTg). Additionally, we also investigated, using 
microdialysis, whether ICSS affects ACh efflux in the VTA, a target region projecting from 
the cell bodies of cholinergic neurons in the PPTg and LDTg.  
 
EXPERIMENTAL PROCEDURES 
Subjects and surgery 
 All of the procedures for animal treatment and surgery were in accordance with the 
guidelines established by the Institute for Experimental Animals of Hamamatsu University 
School of Medicine, and were approved by the University committee for animal experiments.  
 Male Wistar rats (Japan SLC, Hamamatsu, Japan), weighing 230-250 g were used. 
The animals were individually housed in cages, which were maintained on a light-dark cycle 
(lights on from 7 A.M. to 7 P.M.) in a temperature controlled environment (23°C), with food 
and water continuously available. For the immunohistochemical experiment, the rats had 
monopolar electrodes bilaterally implanted in the MFB (3.8 mm posterior to bregma, 1.6 mm 
lateral from the midline and 8.0 mm ventral from the surface of the skull) of the brain under 
sodium pentobarbital (50 mg/kg, i.p.) using stereotaxic coordinates (Paxinos and Watson, 
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1982). The reference electrode, a 1.2 mm watch screw, was attached to the frontal bone. For 
the microdialysis experiment, the animals had an electrode and aguide cannula implanted, 
ipsilateral to the electrode, near the VTA (at a 12° angle with respect to the interaural line; 
6.8 mm posterior to bregma, 1.0 mm lateral to the midline, and 6.0 mm ventral from the 
surface of the skull). The electrode or electrode/cannula assembly was secured with skull 
screws and dental cement, and then a dummy probe was placed inside the cannula. Electrodes 
consisted of a stainless steel wire (0.2 mm in diameter) coated with polyurethane, except for 
the tip. The cannula guide was made from the catheter taken from a 22G JELCOTM I.V. 
catheter placement unit (Johnson and Johnson Medical, Arlington, Texas) as described 
elsewhere (Nakahara et al., 1993). The dialysis probe, which was made from the 25G 
introducing needle taken from the same catheter unit, was concentric in design with a side-
by-side inlet and outlet arrangement and a dialysis tubing. The effective area of the dialysis 
membrane (Cuprophan, 0.23 mm in outer diameter, 10 µm in wall thickness, M.W. cut-off: 
<35000) (Nikkiso, Tokyo, Japan) was 2 mm in length. The dummy probe was made from a 
JELCOTM I.V. stylet. 
ICSS training* 
 Following 5-7 days of post-operative recovery, the rats were placed in a 25.0 x 30.0 x 
28.5 cm transparent acrylic box with a lever and trained to press the lever for the rewarding 
MFB stimulation. Each lever-press delivered a 0.3 sec train of biphasic, rectangular pulses 
with a pulse duration of 0.1 msec and a pulse frequency of 100 pulses/sec on a continuous 
reinforcement schedule. The current intensity was varied by the experimenter, and finally 
fixed at the value between 500 and 800 µA that sustained stable lever-pressing. The subjects 
showing stable lever-pressing with minimal motoric side-effects were chosen for further 
testing. 
Immunohistochemistry* For the immunohistochemical study, ICSS was estimated for 
each electrode on the training day, and one electrode which produced a more vigorous 
response than the other was used on the test day. The immunohistochemical experiment 
started at least 48 hrlater, to wait for Fos expressed following the ICSS training to disappear. 
The experimental animals were placed in the ICSS box and were allowed to press the lever 
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for brain-stimulation reward for 1 hrTwo hours following the final ICSS, each rat received 
an overdose of sodium pentobarbital (100 mg/kg, i.p.) and was perfused transcardially first 
with 250 ml of cold saline followed by 500 ml of cold freshly prepared 3% paraformaldehyde 
and 0.2% picric acid in 0.1 M phosphate buffer (pH 7.4), and finally 250 ml of 10% sucrose 
in 0.1 M phosphate buffer. The brains were removed quickly and immersed in 30% sucrose 
in 0.1 M phosphate buffer overnight for two nights at 4°C. The control animals were 
subjected to the same procedure, except that they received no stimulation on the test day. The 
brains were subsequently cut on a freezing microtome into 50 µm coronal sections.  
 Immunohistochemistry was performed as previouslydescribed (Ishida et al., 2000, 
2001; Maloney et al., 1999; Nakahara et al., 1999). For the immunostaining of Fos protein, 
we used a rabbit polyclonal antibody raised against a peptide corresponding to human c-fos 
amino acid residues 3-16 (diluted 1:5000; Santa Cruz Biotechnology, Santa Cruz, CA). For 
the immunostaining of ChAT and GABA, a mouse anti-ChAT antiserum (1:3000; Chemicon 
International, Temecula, CA) and a mouse anti-GABA antiserum (1:500; Sigma, St. Louis, 
MO) were used, respectively. In this study, Fos was immunostained in the first place and 
ChAT or GABA in the second place. The sections, collected in phosphate buffered saline 
solution (PBS; pH 7.4), were processed first for Fos immunohistochemistry according to the 
instructions for use of streptavidin-biotin system (Histofine SAB-PO(R) kit, Nichirei, Tokyo, 
Japan). After incubation in 10% normal goat serum for 60 min at room temperature, the 
sections were incubated at 4°C overnight with the antibody to Fos. The sections were washed 
three times in PBS and incubated at room temperature for 60 min with a secondary 
biotinylated goat anti-rabbit IgG, washed three times in PBS, and further incubated at room 
temperature for 20 min with a streptavidin-peroxidase complex. After three washes in PBS, 
the reaction products of biotinylated goat anti-rabbit IgG and streptavidin-conjugated 
horseradish peroxidase were visualized using 0.01% diaminobenzidine tetrahydrochloride 
(Sigma) and 0.0003% hydrogen peroxide, and intensified by pretreatment with 0.125% cobalt 
chloride. This method induced a black reaction of Fos-positive cells. Next, after an overnight 
wash in PBS, the sections were again incubated at 4°C overnight with the antibody against 
ChAT or GABA. The tissues were processed using a similar procedure as described above, 
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except that the second reaction was visualized with the avidin-biotin kits (Vector 
Laboratories, Burlingame, CA) using diaminobenzidine tetrahydrochloride as a chromogen 
without cobalt enhancement. This approach produced a brown reaction of ChAT- or GABA-
positive cells. Finally, the sections were mounted on gelatin-coated glass slides, air-dried, 
dehydrated, coverslipped and analyzed with light microscopy. There was no apparent cross-
reactivity between the anti-Fos antibody and each of the anti-ChAT and anti-GABA 
antibodies. Omission of the primary antibodies from the immunocytochemical procedure 
eliminated Fos-, ChAT- or GABA-like immunoreactivity. 
 Cell counting was made from two to four sections/nucleus in each animal under 10 x 
magnification using a microscopic 0.25 x 0.25 mm2 grid. The single- and double-
immunostained cells were counted bilaterally in two regions, PPTg and LDTg. The cell 
counts were averaged per nucleus.  
Microdialysis  
 The microdialysis collections started 2-3 days after the ICSS training. On the morning 
of the experiment, the dummy probe was replaced with the dialysis probe, which was secured 
to the guide cannula using sticky wax. The animals were then placed in the ICSS box from 
which the lever had been removed. The dialysis probe was perfused with a Ringer solution 
(138 mM NaCl, 2.4 mM KCl, 1.2 mM CaCl2, at pH 6.5-7.0)containing 10 µM eserine 
(Wako Pure Chemical Industries, Osaka, Japan), an acetylcholine esterase inhibitor, at a flow 
rate of 2 µl/min. Measurement of steady-state levels of ACh was begun after a 180-min 
stabilization period. Three consecutive samples were collected at 20-min intervals in small 
plastic vials to determine steady-state (basal) levels. Subsequently, the rats were allowed to 
press the lever for brain-stimulation reward for 1 hr. Sample collections continued during and 
for 2 hr after ICSS. ACh levels in dialysates were analyzed by reverse-phase high-
performance liquid chromatography (HPLC) with electrochemical detection. The HPLC 
system (BAC-300 system, EICOM, Kyoto, Japan) consisted of an EP-300 pump, an ECD-
300 electrochemical detector with a WE-PT platinum working electrode, and a PowerChrom 
system (ADI, Sydney, Australia). The detection potential was set at +450 mV against an 
Ag/AgCl reference electrode. Choline and acetylcholine were separated on a reverse-phase 
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Eicompak AC-GEL column (4 µm, 2! x 150 mm) and reacted on an Eicom AC-Enzymepak 
immobilized column (3! x 5 mm) containing acetylcholine esterase and choline oxidase. The 
flow rate was 150 µl/min, and the sensitivity was set to 0.1 nA/V full scale. The mobile phase 
consisted of a 50 mM phosphate buffer (pH 8.2) containing 1.23 µM sodium 1-
decansulfonate and 13.4 µM disodium ethylenediaminetetraacetic acid. Following the 
experiments, all animals were deeply anesthetized with an overdose of sodium pentobarbital 
and perfusedintracardially with 10% formalin in saline. The brains were removed and 
placed in 10% formalin for more than 1 week. Brain tissues were frozen and coronally cut as 
30 µm slices and stained with cresyl violet for the verification of the tip location of cannulas 
and electrodes.  
Statistics  
 To evaluate the effects of stimulation on single- and double-labeled cells in each 
nucleus, the bilateral average cell counts of the cells for the ICSS group were compared, 
using the Mann-Whitney U-test, to the corresponding average for the control group. To 
evaluate the unilateral effects of stimulation on each nucleus, the cell counts for each 
stimulated side was compared, using the Wilcoxon signed rank test, to the corresponding 
values for the unstimulated side in the ICSS groupThe effect of ICSS on extracellular 
levels of ACh was analyzed using one-way repeated measures analysis of variance coupled 
with the least significant difference test for multiple comparisons. The level of significance 
was set at p<0.05. 
 
RESULTS 
Fos expression associated with ICSS 
 In the two brain regions examined, ICSS of the MFB significantly increased the 
expression of Fos when compared with control brains. Moreover, both regions showed a 
significantly higher number of Fos-positive cells on the stimulated side than on the 
unstimulated side. However, the extent to which the MFB stimulation induced Fos expression 
depended on the individual region (Tables 1 and 2). 
Co-localization of Fos expressed following ICSS with either ChAT or GABA 
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 The neurotransmitter phenotype of the cells showing an increased expression of Fos 
was also examined. Even in control animals, there was a significant difference in the number 
of double-labeled neurons in the PPTg and LDTg with GABA-positive/Fos-positive cells 
being much larger than ChAT-positive/Fos-positive cells. This indicates that ChAT-labeled 
neurons in these nuclei did not express Fos as easily as GABA-labeled neurons, even at rest. 
ICSS caused a significant increase in the number of ChAT/Fos double-labeled cells in both 
hemispheres of the LDTg, but with no asymmetry(Table 1 and Fig. 1)In the PPTg, this 
increase was much higher than in the LDTg, but apparently did not reach significance 
because of the variability of the ICSS data. In contrast, significantly increased Fos expression 
was observed in many of the cells that were immunostained for GABA in both regions, with 
a difference in the number of GABA/Fos double-labeled cells between the stimulated and 
unstimulated side (Table 2 and Fig. 1). The mean proportion of co-localization for Fos and 
GABA in the stimulated side represented 52.6±0.16%of all of the Fos- positive cells in the 
PPTg, and 44.4±0.16% in the LDTg. Thus, a large portion of Fos-positive cells following 
ICSS contained GABA. However, a similar proportion of Fos-positive cells also contained 
GABA in the PPTg and LDTg in control brains, thus ICSS did not increase the percentages 
of GABA/Fos double-labeled cells with respect to the total number of Fos-positive cells in 
the two nuclei. 
ACh efflux in the VTA during ICSS 
 In order to examine whether ICSS of the MFB affects the release of ACh in 
cholinergic terminal areas, we monitored, using microdialysis, ACh effluxes from the VTA. 
This area demonstrated a significant increase in ACh (F11,44=28.94; p<0.001) effluxes during 
ICSS (Fig. 2). Thus, the result indicates that there was no relation between the expression of 
Fos in cholinergic cells of the mesopontine tegmentum and the release of ACh in its terminal 
area associated with ICSS. 
 As illustrated in Fig. 3, electrode tips were found within or near the MFB
Microdialysis probe tracts were also confirmed to be located near or inside the VTA. 
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DISCUSSION 
 The present immunohistochemical data demonstrated that ICSS of the MFB induces 
the expression of Fos in cholinergic cell body areas of the PPTg and LDTg, with ipsilateral 
predominance, a result that corresponds with findings in previous reports (Arvanitogiannis et 
al., 1997; Oda et al., 1999). Evidence from double-immunostaining for Fos and ChAT or for 
Fos and GABA revealed, however, that Fos expression induced by the stimulation is mostly 
confined to GABA-, but not ChAT-, immunostained cells which are co-distributed with 
cholinergic neurons in the above regions. Recently, such Fos expression in the PPTg and 
LDTg has also been obtained from another laboratory, using the dual-immunostaining of Fos 
and reduced nicotineamide adenine dinucleotide phosphate-diaphorase as a marker of 
cholinergic neurons (Oda et al., 1999). In addition, consistent with recent evidence (Rada et 
al., 2000), our microdialysis finding confirmed that the rewarding MFB stimulation increases 
ACh efflux in the VTA. 
Absence of Fos expression in cholinergic neurons 
 Surprisingly, many of the cholinergic cells in the PPTg and LDTg did not express Fos 
in response to ICSS. Recently, nicotine, a drug reward, has also been found to induce Fos 
expression in non-cholinergic, but not cholinergic, neurons of the PPTg and LDTg (Lanca et 
al., 2000). Nevertheless, in cats paradoxical sleep is reported to be associated with induction 
of Fos immunoreactivity in ChAT-positive cells of the mesopontine nucleus (Maloney et al., 
1999). Thus, as the cholinergic neurons appear to posses the capability of expressing Fos, it is 
possible that one-hour of ICSS was not sufficient to induce Fos expression in cholinergic 
neurons of the PPTg or LDTg. Noradrenergic and serotonergic neurons, which are most 
active in animals that are awake (Aston-Jones and Bloom, 1981; McGinty and Harper, 1976), 
project to the mesopontine tegmentum (Honda and Semba, 1994; Jones, 1991a). These 
transmitters have been shown to inhibit cholinergic neurons of the LDTg (Koyama and 
Kayama, 1993; Leonard and Llinas, 1994; Luebke et al., 1992; Williams and Reiner, 1993). 
Our recent immunohistochemical study showed ICSS-induced significant increases in the 
number of double-labeled, TH-positive/Fos-positive cells in the locus coeruleus and in the 
number of double-labeled, 5-HT-positive/Fos-positive cells in the dorsal raphe (Ishida et al., 
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2001). It is also possible, therefore, that metabolic activation of cholinergic neurons in the 
PPTg and LDTg was suppressed during ICSS, at least partially, through the excitation of 
noradrenergic and/or serotonergic neurons, thus resulting in very few cholinergic cells 
expressing Fos before and after ICSS. However, this possibility seems to be improbable, 
because previous (Rada et al., 2000) and present microdialysis studies clearly demonstrated 
that ICSS of the lateral hypothalamus increased ACh efflux in the VTA, a target region 
projecting from the cell bodies of the PPTg and LDTg cholinergic neurons. The increase in 
VTA ACh levels observed during ICSS strongly suggests activation of cholinergic cells in 
the mesopontine tegmentum. Fos is not necessarily expressed in every neuron that responds 
to a variety of physiological and pharmacological stimuli (Deutch et al., 1991; Dragunow and 
Faull, 1989; Sagar et al., 1988). Therefore, a lack of Fos induction in the cholinergic neurons 
following ICSS cannot be interpreted as an absence of activity of these neurons. Alternatively, 
it is most likely that cholinergic cells of the LDTg and PPTg did not require the mechanism 
involved in Fos expression for increasing ACh release under our ICSS situation. Such a 
possibility should be confirmed by detecting other transcription factors responsible for 
activation of ACh release associated with ICSS.  
TerminalACh release 
 Presynaptic regulation of the terminal release of neurotransmitters has been found, 
under stressful conditions, in the dopaminergic and serotonergic systems. Tail-pinch stress 
caused an increase in the 5-HT release of serotonergic terminals without enhancing the firing 
activity of serotonergic cells in the raphe (Reuter and Jacobs, 1996; Reuter et al., 1997). 
Furthermore, restraint stress increased extracellular levels of dihydroxyacetic acid, a major 
dopamine metabolite, in the nucleus accumbens, whereas the same stress did not increase Fos 
expression in the VTA dopaminergic neurons projecting to the nucleus accumbens (Deutch et 
al., 1991). Therefore, there still remains a possibility that terminal ACh release occurred 
through presynaptic mechanisms, independently of alterations in the cholinergic neuronal 
activity of self-stimulating animals. Presynaptic regulation of terminal release may be one of 
the common features of the central neurotransmitter system. 
Co-expression of Fos and GABA 
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 A previous study by Ford et al. (1995) reported that GABA-ergic cells were more 
numerous than ChAT-positive cells in the LDTg and PPTg. This finding appears to be 
incompatible with the present result showing that the proportion of ChAT- and GABA-
positive cells was similar in these nuclei. However, this incompatibility might be due to 
different methods employed. There is a possibility that since Ford et al. used an antibody to 
glutamic acid decarboxylase (GAD) to detect GABA-ergic neurons, with the brains 
pretreated with colchicine to maximize levels of GAD within the cell bodies of neurons, they 
could not properly determine GABA-ergic neurons. 
 We demonstrated for the first time that ICSS increased Fos expression in GABA-
ergic cells which are co-distributed with cholinergic cells in the PPTg and LDTg (Ford et al., 
1995; Honda and Semba, 1995; Jones, 1991b). However, in control brains, the percentage of 
GABA/Fos double-labeled neurons was 41 to 64% of all of the Fos-positive cells, and this 
percentage was unchanged in the ICSS-treated brains. This indicates that ICSS increased just 
the total number of Fos-positive cells, but not the proportion of GABA/Fos double-labeled 
neurons in these brain regions. In addition, previous (Hunt and McGregor, 1998; Ishida et al., 
2001) and present studies showed that Fos expression is very low in dopaminergic neurons of 
the VTA and cholinergic neurons of the PPTg and LDTg which are both important for brain-
stimulation reward. It is likely, therefore, that spontaneous activity in dopaminergic and 
cholinergic neurons is under restraint because their activity has major effects on overall 
locomotion, cortical activation and reward (Sheel-Kruger and Willner, 1991; Yeomans, 
1995). The GABA-ergic neurons, which restrain these dopaminergic and cholinergic neurons, 
appear to be even more important when dopaminergic and cholinergic neurons release their 
transmitters as they do during ICSS and other rewarding events. Further research is needed to 
determine a precise mechanism by which these Fos-expressing GABA-ergic cells influence 
neighboring cholinergic neurons. 
Conclusions 
 In summary, the present findings show that Fos expression increased by ICSS of the 
MFB was limited mostly to GABA-ergic, but not cholinergic, neurons in the LDTg and PPTg, 
whereas the same stimulation enhanced extracellular ACh in the VTA. Thus, during ICSS, 
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cholinergic cells of the mesopontine tegmentum may excite but not require the mechanism 
involved in Fos expression for ACh release, while excitation of GABA-ergic neurons during 
this situation may need the Fos mechanism. Mesopontine GABA-ergic as well as cholinergic 
neurons may be an important component of the neurochemical mechanisms underlying ICSS 
reward. 
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Table 1. Number of neurons labeled for ChAT or Fos and neurons containig both ChAT and Fos 
immunoreactivities 
 
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
 control ICSS 
                 –––––––––––––––––––––––––––––––         –––––––––––––––––––––––––––––––– 
 left (n ) right (n ) stimulated (n ) unstimulated (n ) 
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
PPTg 
ChAT† 15.8±2.4 (9) 15.2±1.9 (9) 19.0±2.0 (8) 20.4±2.4 (8) 
Fos‡ 1.7±0.4 (9) 2.0±0.7 (9) 10.7±1.7**x (8) 3.5±1.1 (8) 
ChAT/Fos§  0.1±0.1 (9) 0.2±0.1 (9) 0.8±0.4 (8) 0.5±0.4 (8) 
 
LDTg 
ChAT† 39.6±3.8 (8) 39.4±3.6 (8) 51.2±4.4 (8) 48.4±3.7 (8) 
Fos‡ 9.0±1.9 (8) 8.3±1.3 (8) 21.6±3.2*x (8) 16.9±2.8 (8) 
ChAT/Fos§ 0.4±0.3 (8) 0.5±0.3 (8) 1.3±0.4* (8) 1.1±0.2 (8) 
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
†ChAT cell numbers correspond to the mean±SEM of the total number of ChAT-positive cells counted 
unilaterally and averaged for two to four sections per nucleus. 
‡Fos cell numbers correspond to the mean ±SEM of the total number of Fos-positive cells counted unilaterally 
and averaged for two to four sections per nucleus.   
§ChAT/Fos cell numbers correspond to the mean±SEM of the total number of double-labeled cells counted 
unilaterally and averaged for two to four sections per nucleus.   
*p < 0.05, **p < 0.01; combined stimulated and unstimulated counts differ from the combined values in control 
group. xp < 0.05; differences between stimulated and unstimulated counts in ICSS group. 
 
  
 
 
19 
Table 2. Number of neurons labeled for GABA or Fos and neurons containig both GABA and Fos 
immunoreactivities 
 
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
 control ICSS 
                –––––––––––––––––––––––––––––––         ––––––––––––––––––––––––––––––––– 
 left  (n ) right (n ) stimulated (n ) unstimulated (n ) 
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
PPTg 
GABA† 16.4±0.6 (8) 16.8±0.8 (8) 18.6±0.9 (9) 16.9±0.4 (9) 
Fos‡ 1.8±0.6 (8) 1.4±0.6 (8) 17.1±1.8***xx (9) 8.8±1.0 (9) 
GABA/Fos§  0.9±0.4 (8) 0.9±0.5 (8) 9.0±0.8***x (9) 4.7±0.5 (9) 
 
LDTg 
GABA† 28.3±1.3 (8) 29.5±1.9 (8) 32.0±1.8 (9) 32.9±1.6 (9) 
c-Fos‡ 8.3±1.4 (8) 8.4±1.2 (8) 25.7±1.7***xx (9) 17.6±1.1 (9) 
GABA/c-Fos§  3.4±0.6 (8) 3.8±0.6 (8) 11.4±0.8***x (9) 8.4±0.8 (9) 
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
†GABA cell numbers correspond to the mean±SEM of the total number of GABA-positive cells counted 
unilaterally and averaged for two to four sections per nucleus. 
‡Fos cell numbers correspond to the mean ±SEM of the total number of Fos-positive cells counted unilaterally 
and averaged for two to four sections per nucleus.   
§GABA/Fos cell numbers correspond to the mean±SEM of the total number of double-labeled cells counted 
unilaterally and averaged for two to four sections per nucleus.   
***p < 0.001; combined stimulated and unstimulated counts differ from the combined values in control group. 
xp < 0.05, xxp < 0.01; differences between stimulated and unstimulated counts in ICSS group. 
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FIGURE LEGENDS 
Fig. 1. A and B: Photomicrographs of neurons immunoreactive for either Fos or ChAT in 
the mesopontine tegmentum of ICSS rats. Black and white arrowheads indicate single-
labeled ChAT- and Fos-positive cells, respectively. C and D: Photomicrographs of neurons 
immunostained for both Fos and GABA in the mesopontine tegmentum of ICSS animals. 
White arrows indicate double-labeled cells. Black arrowheads indicate adjacent single-
labeled GABA-positive cells. The black circle in the drawing indicates the location of areas 
where photomicrographs were taken. Scale bar, 20 µm. 
 
Fig. 2. Effect ofICSSat the MFB on the dialysate levels of AChin the VTA during 
continuous perfusion of the Ringer solution with eserine (10 µM). Inset displays ICSS rates 
every 20 min. Values are the mean± SEM (n=5). During ICSS of the MFB, animals received 
a mean ±SEM of 1104.2±103.2 trains of stimulations in the first 20-min ICSS session, 
1298.8±102.3 in the second 20 min session, and 1129.0±53.8 in the third 20 min session. 
**p<0.01 significant difference from basal levels. 
 
Fig. 3. Coronal sections showing the site of the electrode placement (upper) and 
microdialysis membrane placement (lower). The solid and open circles indicate electrodes 
used in immunohistochemical and microdialysis experiments, respectively. The electrodes 
are all depicted on the left side of the brain for convenience sake. The numbers above each 
section indicate the distance (mm) posterior (-) to bregma. Drawings are adopted from the 
atlas of Paxinos and Watson (1982). mfb, medial forebrain bundle; VTA, ventral tegmental 
area.  
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Figure 3 
 
